IMCR

Immunocore Holdings plc

35.81 USD
-0.12 (-0.33%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Immunocore Holdings plc stock is down -22.24% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 10 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
24 May 13:36 21 Jun, 2024 50.00 PUT 50 1254
24 May 13:38 21 Jun, 2024 50.00 PUT 73 1254
24 May 13:44 21 Jun, 2024 50.00 PUT 100 1254
24 May 13:44 21 Jun, 2024 50.00 PUT 100 1254
24 May 13:44 21 Jun, 2024 50.00 PUT 100 1254
24 May 13:44 21 Jun, 2024 50.00 PUT 100 1254
24 May 13:45 21 Jun, 2024 50.00 PUT 100 1254
14 Jun 14:56 19 Jul, 2024 40.00 PUT 150 176
17 Jun 17:53 20 Dec, 2024 40.00 PUT 181 13
21 Jun 17:31 20 Dec, 2024 40.00 PUT 72 268

About Immunocore Holdings plc

Immunocore Holdings plc engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. KIMMTRAK is in Phase I/II trials for patients with unresectable or metastatic uveal melanoma. The company's programs for infectious diseases include IMC-I109V, which is in a clinical trial in patients with chronic hepatitis B virus.

  • HC Wainwright & Co.
    Wed Jun 5, 11:33
    buy
    confirm
  • Needham
    Mon Jun 3, 06:20
    buy
    confirm
  • HC Wainwright & Co.
    Thu May 30, 07:04
    buy
    confirm
  • Needham
    Wed May 29, 12:14
    buy
    confirm